An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection

Overview of attention for article published in Frontiers in immunology, December 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 13 news stories from 13 outlets.

Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines, announced…

Additional pre-clinical data of Avacc 10®indicate reduction in upper respiratory tract viral load and cross neutralization of…

Press Release Monday, September 12th 2022, 2:11 AM EDTSponsored: Advertising Content SOURCE Intravacc BILTHOVEN, Netherlands…

Additional pre-clinical data of Avacc 10®indicate reduction in upper respiratory tract viral load and cross neutralization of…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 9 additional news stories.